MUC1 core protein as a marker of gallbladder malignancy

This publication has 10 references indexed in Scilit:

• Increased expression of MUC1 in advanced pancreatic cancer
  The Esophagus, 2003
• Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: Its relationship with tumor progression and prognosis
  Pathology International, 2002
• Mucin core protein expression in extrahepatic bile duct carcinoma is associated with metastases to the liver and poor prognosis
  Cancer, 1999
• MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients
  Journal of Clinical Pathology, 1998
• Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas
  International Journal of Cancer, 1998
• DF3 antigen, a human epithelial cell mucin, inhibits adhesion of eosinophils to antibody-coated targets.
  The Journal of Immunology, 1990
• Expression of genes coding for pS2, c‐erbB2, estrogen receptor and the H23 breast tumor‐associated antigen
  FEBS Letters, 1990
• Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients
  Breast Cancer Research and Treatment, 1985
• Monoclonal antibodies against human milk‐fat globule membranes detecting differentiation antigens of the mammary gland and its tumors
  International Journal of Cancer, 1984
• Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation.
  Proceedings of the National Academy of Sciences, 1982